Non–Small Cell Lung Cancer: Other Actionable Mutations
2 Bekeken
• 07/04/23
0
0
insluiten
administrator
abonnees
Corey J. Langer, MD; V****iliki Papadimitrakopoulou, MD; and Hossein Borghaei, DO, elucidate the potential value of less common actionable mutations in determining appropriate treatment for patients with non–small cell lung cancer.
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties